A Study to Assess Safety and Tolerabiltiy Associated With a Switch From Oral Antipsychotic Medications to Long-Acting Injectable Risperidone in Patients With Schizophrenia.

This study has been completed.

Study NCT00034775 Information provided by Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

First Received: May 2, 2002 Last Updated: March 14, 2007 History of Changes

No Study Results Posted for this Study

Study Status:	This study has been completed.
Estimated Study Completion Date:	October 2002
Estimated Primary Completion Date:	No date given